ArticleTherapeutics and clinical risk management2025
Rehabilitation Combined with Coagulation Tests for the Prevention of DVT in Patients After Hypertensive Intracerebral Hemorrhage Surgery.
Article in Therapeutics and clinical risk management, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To evaluate the efficacy of ultra-early rehabilitation combined with coagulation monitoring in preventing deep vein thrombosis (DVT) in patients following surgical intervention for hypertensive intracerebral hemorrhage (HICH). Methods: A retrospective cohort study was conducted involving 126 HICH patients treated at the Neurosurgery ICU of The Affiliated Hospital of Xuzhou Medical University and the Rehabilitation Department of Xuzhou Central Hospital between January 2023 and December 2024. Participants were stratified into an experimental group (ultra-early rehabilitation with daily coagulation testing, n=63) and a control group (conventional care, n=63) based on the management protocol they received during their hospitalization. Hemodynamic parameters, muscle strength, and coagulation markers were assessed at baseline (T0: pre-intervention), T1 (postoperative day 1), T7 (postoperative day 7), and T14 (postoperative day 14). Results: Baseline characteristics demonstrated comparability between groups (P>0.05). The experimental group exhibited superior muscle strength recovery in both upper and lower extremities, with statistically significant differences emerging at T14 (P<0.05). Coagulation parameters including fibrinogen (FIB), fibrinogen degradation products (FDP), D-dimer, thrombin-antithrombin III complex (TAT), plasmin-antiplasmin complex (PIC), and thrombomodulin (TM) demonstrated progressive decline in the experimental cohort. At T7, FIB, FDP, and D-dimer levels were significantly lower in the experimental group compared to controls (P<0.05), with more pronounced reductions observed at T14. TAT, PIC, and TM similarly demonstrated substantial decreases at T14 (P<0.01). DVT incidence was significantly reduced in the experimental group (12.70% vs 31.75%, P<0.05). Conclusion: Ultra-early rehabilitation guided by systematic coagulation monitoring appears to be associated with favorable modulation of hemostatic markers (FIB, FDP, D-dimer, TAT, PIC, TM) and enhanced muscle strength recovery following HICH surgery. This integrated approach may effectively reduce postoperative DVT incidence, offering a promising strategy for thromboprophylaxis management.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.